With the trillions of dollars pumped in to prop up the economy
in 2020, and with a substantial portion of that money focused on
health care, we can expect a surge of health care litigation in
2021 addressing false claims and other fraud.
The US Department of Justice reported recovering only $2.2
billion from both settlements and judgments in False Claims Act
(FCA) investigations and litigation in 2020. This was the lowest
level since 2008 and almost $1 billion less than what was recovered
in 2019. Of that, the vast majority of recoveries came from the
health care and life sciences industries, meaning that health care
remains the prime target for FCA investigations and litigation.
Indeed, the government and individual qui tam plaintiffs
collectively filed more FCA cases in 2020 than in any past year. At
least with regards to qui tam plaintiffs, the vast majority of
filings were related to health care. Given the 2020 filings, the
ongoing pandemic, and the government's